Mattias Carlsten

11PUBLICATIONS
24CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 12, 2026
Maneuvering ofCS toward precision medicine for AML?

Mattias Carlsten

|Jan 20, 2025
Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation.

Panagiota Maravelia, Haidong Yao, Curtis Cai

|May 20, 2024
Redirecting NK cells to the lymph nodes to augment their lymphoma-targeting capacity.

Laura Sanz-Ortega, Caroline Leijonhufvud, Lisanne Schoutens

|Jan 05, 2024
Harnessing upregulated E-selectin while enhancing SDF-1α sensing redirects infused NK cells to the AML-perturbed bone marrow.

Laura Sanz-Ortega, Agneta Andersson, Mattias Carlsten

|Nov 08, 2023
Improved Leukemia Clearance After Adoptive Transfer of NK Cells Expressing the Bone Marrow Homing Receptor CXCR4R334X.

Filip Segerberg, Mélanie Lambert, Laura Sanz-Ortega

|Aug 21, 2023
Rough operators: sphingomyelinase inhibitors spike NK cells to kill cancer.

Mattias Carlsten, Yenan T Bryceson

Pageof 2

Frequent Collaborators

2 joint publications

Filip Segerberg

2 joint publications

Laura Sanz-Ortega

1 joint publications

Cynthia St Hilaire

1 joint publications

John Daly